September 11, 2025: Eli Lilly filed a motion seeking to centralize all federal NAION lawsuits related to GLP-1 receptor agonist drugs
Semaglutide is one of the most studied weight loss medications available today
According to the Danish Medicines Agency, diabetes, high blood pressure, high cholesterol, and severe obesity are some of the known risk factors for Naion
To assess the utility of the model in a real world setting, we applied the model to a set of EHR data not used during model construction, and predicted efficacy at 6 months, assuming that the drug type and final dose was unknown at time point zero
Using nasal spray format Bioavailability through nasal spray is genuinely poor for BPC-157, with subcutaneous injection and properly formulated oral administration being the only validated approaches
Formulation suited to medical conditions